- Home
- A-Z Publications
- Current Pharmaceutical Design
- Fast Track Listing
Current Pharmaceutical Design - Online First
Description text for Online First listing goes here...
65
results
1 - 20 of 65 results
-
-
QSAR and Molecular Docking Studies on Uracil-Based Benzoic Acid and Ester Derivatives to Explore Novel Dipeptidyl Peptidase-4 Inhibitors
Authors: Pradeep Pilania and Prithvi SinghAvailable online: 17 March 2025More LessBackground Today, diabetes mellitus (DM) is considered a major global health problem and, especially diabetes mellitus type-2 (T2DM), which accounts for 90-95% of all diabetes cases. Among the novel glucose-lowering agents, dipeptidyl peptidase-4 (DPP-4) inhibitors have been extensively studied in recent years. Objectives This paper integrates a QSAR study and docking analysis of a series of uracil-based benzo Read More
-
-
-
Vegetable Oils in Skin Whitening - A Narrative Review
Available online: 17 March 2025More LessPlants are a source of a variety of compounds, such as vegetable oils, which are rich in fatty acids and possess skin-whitening properties. Considering the hyperpigmentation treatment challenges (lack of efficacy or aggressiveness), the constant search for new whitening substances is necessary. Given vegetable oils’ potential and application in dermatological and cosmetic products, we reviewed the scientific literature Read More
-
-
-
Recent Developments in the Synthesis of Benzothiazoles and their Anti-cancer Mechanistic Discoveries
Authors: Wafaa A. Zagha, Galal H. Elgemeie, Rasha A. Azzam, Safa A. Aljuhr and Tamer M. SakrAvailable online: 05 March 2025More LessBenzothiazole derivatives have garnered considerable attention owing to their versatile chemical scaffold and remarkable biological activities. The article provides an in-depth analysis of the diverse structural modifications and strategies employed to enhance the anticancer potential of these compounds from the period of 2020 to 2024. It discusses the role of structure-activity relationships (SAR) and computational approache Read More
-
-
-
Nutraceutical Interventions for Mitigating Skin Ageing: Analysis of Mechanisms and Efficacy
Available online: 03 March 2025More LessSkin ageing is influenced by intrinsic factors such as genetics and hormones, as well as extrinsic factors like environmental exposure, ultraviolet (UV) radiation, and diet. These factors lead to biochemical, biological, and structural changes in the skin. Plant-derived compounds with antioxidant and anti-inflammatory properties have emerged as potential anti-ageing agents. This comprehensive review, spanning data from 1997 t Read More
-
-
-
Exploring the Potential Mechanisms of Zuo Gui Pill for the Treatment of Knee Osteoarthritis Based on Network Pharmacology and Molecular Docking Techniques
Authors: Yulin Wang, Jiahao Zhang, Junzheng Liu, Tun Liu, Jiaxin Zhao, Yiling Guo, Xinyi Zhang and Wei WangAvailable online: 28 February 2025More LessBackground Zuo Gui pill (ZGP) is a herbal compound formulation used to treat knee osteoarthritis (KOA), but its underlying mechanisms are still unclear. This study aimed to initially elucidate the molecular mechanisms of ZGP in treating KOA using network pharmacology and molecular docking techniques. Methods We collected information on the drug compounds and targets from TCMSP, HERB, BATMAN-TCM, and UniPr Read More
-
-
-
Esketamine Regulates Mitophagy through ULK1/FUNDC1 Signaling Pathway to Improve LPS-induced Acute Respiratory Distress Syndrome
Authors: Mei Ding, Ping Pei, Weihua Liu, Yingli Cao, Yiqi Weng and Wenli YuAvailable online: 28 February 2025More LessBackground As a heterogeneous clinical syndrome, acute respiratory distress syndrome (ARDS) is caused by infection-associated inflammation with limited treatment options. Esketamine possesses anti-inflammatory properties, and it is effective in treating lung diseases. Objective This study aimed to unveil the efficacy and mechanism of esketamine in ARDS. Methods Lipopolysaccharide (LPS) is widely used to induce inflamm Read More
-
-
-
Leveraging AI and Natural Compounds: Innovative Approaches in the Diagnosis and Treatment of Hepatocellular Carcinoma
Authors: Mohd Suhail, Mohammad Tarique, Shams Tabrez and Darshan BadalAvailable online: 28 February 2025More LessLiver cancer, particularly Hepatocellular Carcinoma (HCC), remains a significant global health challenge owing to its high incidence and position as the fourth leading cause of cancer-related mortality. HCC represents 75-85% of all liver cancer cases and ranks as the sixth most prevalent cancer globally. Several factors, including late-stage diagnosis, limited treatment effectiveness, resistance to conventional therapies, and adver Read More
-
-
-
Synthesis and Characterization of Zn(1-x-y)MnxCoyO NPs for Liver Cancer Treatment
Available online: 26 February 2025More LessIntroduction In this study, pure and cobalt manganese-doped ZnO nanoparticles (Zn(1-x-y)MnxCoyO NPs) at varying concentrations were synthesized through sol-gel method, and zinc acetate dihydrate, manganese nitrate, cobalt acetate, and diethyl amine were used as precursors, with samples finally calcined at 700oC. Method The hexagonal wurtzite structure of pure and co-doped ZnO NPs was confirmed by X-ray Read More
-
-
-
Cancer Drug Targeting: Molecular Mechanism, Approaches, and Regulatory Framework
Authors: Rushikesh Somnath Chandel and Hitesh Kumar DewanganAvailable online: 14 February 2025More LessNovel vaccine formulations called nano vaccines which use nanoparticles (NPs) as adjuvants or carriers, are being developed in place of conventional vaccines. The field of study on peptide-based nano vaccines is enlarging fast as a result of combining antigenic peptides with nano-transport systems. This paper explores advancements in anticancer nano vaccines, focusing on their mechanisms, challenges, and oppo Read More
-
-
-
Systems Pharmacology-based Drug Discovery and Active Mechanism of Ganoderma lucidum Triterpenoids for Type 2 Diabetes Mellitus by Integrating Network Pharmacology and Molecular Docking
Authors: Junkai Shi, Jialiang Chen, Chitong Cheng, Wei Li, Ming Li, Shuhong Ye, Zhaofang Liu, and and Yan DingAvailable online: 13 February 2025More LessBackground: Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease primarily characterized by insufficient insulin secretion or reduced insulin sensitivity in the body's cells, leading to persistently high blood glucose levels. Ganoderma lucidum triterpenoids, as important secondary metabolites of Ganoderma lucidum, have shown preliminary potential efficacy in the treatment of T2DM according to existing research. Read More
-
-
-
Eprosartan Reduces Inflammation and Oxidative Stress in Ethanol-induced Hepatotoxicity
Available online: 12 February 2025More LessIntroduction Eprosartan is an effective blood pressure medication that blocks the Angiotensin Type 1 (AT1) receptor. The studies conducted on Eprosartan showed anti-oxidative stress effects and modulating inflammatory mechanisms. The current research is designed to clarify and examine the possible advantageous impacts of Eprosartan against chronic ethanol-induced hepatic damage. Method Twenty-four male Read More
-
-
-
Difficulties in Using Natural Herbal Substances and their Current use in Some Pharmaceutical Dosage Forms
Authors: Ece Özcan Bülbül and Neslihan Üstündağ OkurAvailable online: 11 February 2025More LessAim Random use of natural herbal products affects the treatment of diseases. In this review, the limitations that may be encountered in using natural substances of plant origin and the studies on using these substances in treating cancer, cognitive disorders, heart diseases, diabetes, and microbial diseases are examined and summarized. Background People worldwide use herbal products derived from natural plants to sol Read More
-
-
-
Advances in Machine Learning Models for Healthcare Applications: A Precise and Patient-Centric Approach
Available online: 11 February 2025More LessBackground Healthcare is rapidly leveraging machine learning to enhance patient care, streamline operations, and address complex medical issues. Though ethical issues, model efficiency, and algorithmic bias exist, the COVID-19 pandemic highlighted its usefulness in disease outbreak prediction and treatment optimization. Aim This article aims to discuss machine learning applications, benefits, and the ethical and pract Read More
-
-
-
Recent Advances in Cationic Nanoemulsions for Drug Delivery: Preparation, Properties, and Applications
Authors: Huanfan He, Jiayu Li, Hong Meng, Yifan He, Xiaojing Pei and Ze ZhangAvailable online: 11 February 2025More LessNanoemulsions have gained popularity as drug delivery vehicles owing to the enhanced solubility of insoluble drugs, the augmented stability of photo- and thermosensitive substances, and the facilitation of transdermal permeation of efficacy substances. As the cell surfaces of the skin, cornea, gastrointestinal mucosa, and other cells in living organisms carry negative charges, cationic nanoemulsions (CNE) mainly promo Read More
-
-
-
Therapeutic Effects and Mechanisms of Icaritin in Parkinson's Disease
Authors: Chongbo Zheng, Lizhen Wu, Liang Luo, Jiating Cai, Zhihua Huang and Keqiang TianAvailable online: 10 February 2025More LessParkinson's Disease (PD) is a neurodegenerative disorder of the central nervous system (CNS). Given the increasing age of the general population, PD has emerged as a significant public health and societal concern, impacting both individual well-being and socioeconomic progress. The present interventions have proven insufficient in impeding the progressive nature of PD. Consequently, it is imperative to promptly identify effica Read More
-
-
-
Potential New Treatments for Chronic Kidney Diseases: A Concise Review
Available online: 06 February 2025More LessChronic Kidney Disease (CKD) affects about 37 million Americans. Approximately 20% of patients with high blood pressure and 33% of patients with diabetes have kidney disease. CKD is most common among people aged 65 or older and is slightly more common in women. It substantially impacts certain ethnic groups more than others and is associated with a huge financial burden. End-Stage Kidney Disease (ESKD) is trea Read More
-
-
-
SNHG10: A Novel Long Non-coding RNA with Multifaceted Roles in Human Cancers
Authors: Haodong He, Jingjie Yang, Yan Zhou, Lihan Chen, Chuyuan Liao, Ting Gong, Tongtong Li, Haoran Liu, Yunfei Pan, Pengbo Zhang, Xiaolan Li and Chengfu YuanAvailable online: 05 February 2025More LessLong non-coding RNAs (lncRNAs) are a type of RNA with a length of more than 200 nucleotides. They do not encode proteins but are crucial in regulating gene expression and affecting the malignant biological behavior of cancer. Small nucleolar RNA host gene 10 (SNHG10) is a novel lncRNA that plays a regulatory role in many malignant tumors. Several recent studies have shown that SNHG10 is aberrantly expressed in vario Read More
-
-
-
Exploring Latest Expansions in Solid Lipid-based Nanoparticle Technology for Treatment of Cancer
Available online: 04 February 2025More LessThe field of cancer therapy has witnessed significant strides with the emergence of innovative drug delivery systems and one such promising avenue is solid lipid-based nanoparticle (SLN) technology. This abstract provides a complete overview of current advances in developing SLNs for effective cancer treatment solid lipid nanoparticles (NPs) represent a novel drug delivery platform characterized by their unique compos Read More
-
-
-
Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency
Authors: Wusheng Zhong, Tao Chen, Ling Chen, Yaqi Xing, Haorui Lin, Shuli Xie, Mateen Nawaz, Danmei Huang, Zhanqin Huang, Jun Lu, Zhiming Chen and Yongdong NiuAvailable online: 04 February 2025More LessAim Quercetin, a bioactive flavonoid extracted from traditional Chinese medicine, has anti-hepatocellular carcinoma effects. Farnesoid X receptor (FXR), a nuclear receptor highly expressed in the liver, plays important roles in maintaining hepatic glucose homeostasis, anti-inflammation, liver regeneration, and anti-cancer properties. Whether quercetin regulates the glycolysis/glycolysis pathway through FXR signaling remains Read More
-
-
-
Efficacy of Roxadustat in Anemia with Chronic Kidney Disease
Authors: Yongda Lin, Chunlin Liao, Lingqian Zheng, Wenmin Chen, Tianbiao Zhou and Tianyu LiAvailable online: 04 February 2025More LessIntroduction Anemia is one of the complications of chronic kidney disease (CKD), and its incidence gradually increases as the disease progresses. A major cause of such anemia is the severe erythropoietin deficiency in CKD. Therefore, improvement in red blood cell production is a choice of treatment. Erythropoiesis-stimulating agents (ESAs) have been used for the therapy of anemia induced in CKD. Roxadustat is a novel dr Read More
-